Connor, Clark & Lunn Investment Management (CC&L)
NRIX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Nurix Therapeutics NRIX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NRIX Stock Details NRIX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$568K Buy
2024
Q3 		– Sell
2024
Q2 		$1.3M Sell
2024
Q1 		$3.49M Buy
2023
Q4 		$1.91M Buy
2023
Q3 		$1.45M Buy
2023
Q2 		$1.3M Buy
2023
Q1 		$116K Buy